Millennium Cancer Center

What Millennium Cancer Center does

Millennium Cancer Center (MCC) is a single-location, comprehensive cancer care center in Gurugram, Haryana, India, founded in approximately 2017 by Dr. Gurdeep S. Sethi, a US-trained triple-board-certified oncologist returning to India after 26 years of American practice. The center offers an integrated continuum of oncology services under one roof, including cytotoxic chemotherapy, immunotherapy (with a self-claimed pioneering dendritic cell therapy offering), molecular/targeted therapy, hormone therapy, hematology, surgical oncology, radiation oncology, genetic testing and counseling, palliative care, and nutritional support. Its flagship differentiated product is the PanTum® Detect multi-tumor screening blood test, which uses EDIM (Epitope Detection in Monocytes/Macrophages) technology to detect two patented enzyme biomarkers (Apo10 and TKTL1) in asymptomatic individuals, with reported IVD CE-certified sensitivity of 97.5% and specificity of 99%.

The business operates on a fee-for-service, quote-based pricing model serving individual cancer patients and at-risk screening customers, with no publicly disclosed pricing or insurance arrangements. Distribution runs through direct patient visits to the Golf Course Road facility, an at-home sample collection network for PanTum Detect, and a global online second opinion service leveraging the founder's expertise. The 12-person team delivers care through a luxury outpatient chemotherapy suite and daycare center, with complex surgical and inpatient cases referred to empanelled partner hospitals. The center also generates ancillary wellness revenue from IV infusion therapies and dietitian services.

The company is privately held, founder-owned, and operates without disclosed external funding, board composition, or institutional investors. Its competitive positioning rests on the founder's credentials, exclusive access to PanTum Detect technology in India, and a "first-of-its-kind" comprehensive-care brand narrative, though revenue scale, headcount, and geographic footprint remain modest.

Name

Millennium Cancer Center

Legal name

Millennium Cancer Center

Website

https://millenniumcancercenter.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Millennium Cancer Center is a single-location comprehensive oncology clinic in Gurugram, India, founded by US-trained oncologist Dr. Gurdeep S. Sethi, offering chemotherapy, immunotherapy, targeted therapy, surgical oncology, and the proprietary PanTum® Detect multi-tumor screening blood test to cancer patients and at-risk individuals.

Ownership category

akta.pro rank

Product category

Oncology / Cancer Care Services

NAICS

Other Ambulatory Health Care Services (6219), Ambulatory Health Care Services (621), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)

akta.pro secondary industries

Oncology & Cancer Specialty Hospitals (HLAFAHAC), Medical Oncology (HLAKAFAB), Oncology Telemedicine Platforms (HLALAGAH)

Keywords

• Oncology treatment services
• Cancer diagnostics
• Immunotherapy services
• Precision medicine oncology
• Multi-tumor screening tests

Headquarters

HQ city

Gurugram

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Medical Consultation Services: Oncology consultations with specialists including medical oncologists, surgical oncologists, and radiation oncologists for diagnosis, treatment planning, and second opinions.
2. Cancer Treatment Services: Revenue from chemotherapy, immunotherapy, targeted therapy, hormone therapy, and other treatment modalities administered at the facility.
3. Diagnostic Testing: Revenue from PanTum Detect blood tests and other diagnostic services including genetic testing, blood work, and imaging coordination.
4. IV Infusion Therapy: Revenue from wellness IV therapies including detoxification, immunity boosters, skin brightening, and energy infusions.
5. Daycare Services: Revenue from daycare cancer treatments including chemotherapy, immunotherapy, blood transfusions, and other short therapies that do not require overnight admission.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

Millennium Cancer Center is a comprehensive outpatient cancer care facility that delivers integrated oncology services — diagnosis, treatment, and supportive care — for cancer patients. Its offerings span medical oncology (chemotherapy, immunotherapy, targeted therapy, hormone therapy), hematology, surgical oncology, radiation oncology, and genetic testing, anchored by its proprietary PanTum® Detect multi-tumor screening blood test and dendritic cell immunotherapy. Support services include palliative care, cancer counseling, nutritional support, daycare infusion, IV infusion therapy, and global online second opinions.

Product overview

Millennium Cancer Center is a comprehensive cancer care hospital offering a unified set of integrated oncology services. The center provides PanTum® Detect as its flagship multi-tumor screening blood test, complemented by a full spectrum of treatment services including Cytotoxic Chemotherapy, Immunotherapy (including dendritic cell therapy and checkpoint inhibitors), Molecular/Targeted Therapy, Hormone Therapy, Hematology, Surgical Oncology, and Radiation Oncology. Support services include Genetic Testing/Genetic Counseling, Cancer Counseling, Palliative Care, Wellness and Nutritional Support, and IV Infusion Therapy. The center operates a dedicated DayCare Center for outpatient treatments and offers Second Opinion Services for patients seeking expert consultations.

Differentiator

Problem solved

Functional benefit

Products and services

• PanTum® Detect Multi-Tumor Screening Blood Test A multi-tumor screening blood test using EDIM® (Epitope Detection in Monocytes/Macrophages) technology to detect patented enzyme biomarkers Apo10 and TKTL1 in immune cells; screens asymptomatic healthy individuals for silently growing benign, premalignant, or malignant tumors. IVD CE certified with 97.5% sensitivity and 99% specificity.
• Cytotoxic Chemotherapy Cancer treatment using anti-cancer drugs that kill cancer cells directly, administered in the center's luxury outpatient chemotherapy suite.
• Immunotherapy Cancer treatment that uses parts of a patient's immune system to fight cancer, including checkpoint inhibitors, monoclonal antibodies, and dendritic cell therapy.
• Molecular / Targeted Therapy Personalized cancer treatment targeting specific genes, proteins, or molecular abnormalities unique to each patient's cancer, informed by NGS gene sequencing.
• Hormone Therapy Cancer treatment using medicines to block the effects of hormones that fuel certain cancers; applicable for breast, prostate, ovarian, and uterine cancers.
• Hematology Diagnosis and treatment of blood disorders and blood cancers including leukemia, lymphoma, and multiple myeloma.
• Surgical Oncology Cancer surgery using minimally invasive laparoscopic and robotic techniques, performed at empanelled world-class hospitals.
• Radiation Oncology Cancer treatment using radiation therapy to treat cancer and relieve symptoms.
• Genetic Testing and Genetic Counseling

Quantifiable outcome

• PanTum Detect sensitivity of 97.5% and specificity of 99% for multi-tumor screening
• +1 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Rajiv Gandhi Cancer Institute and Research Centre: Dedicated not-for-profit/affordable cancer specialty hospital in Delhi NCR offering medical, surgical and radiation oncology with daycare services. Comparable as a Delhi-NCR cancer specialty center serving similar patient segments (with mixed affordability mix).
• HealthCare Global Enterprises (HCG): India's largest dedicated cancer hospital network with daycare chemotherapy, precision oncology, immunotherapy, and second-opinion services across 20+ centers. Most directly comparable to MCC on multi-modality oncology services, premium private positioning, and use of advanced diagnostics and immunotherapies.
• Cytecare Hospital: Bengaluru-based dedicated cancer hospital with organ-specific specialty centers, daycare chemo, immunotherapy, and precision oncology. Comparable to MCC as a focused private cancer specialty provider emphasizing personalized treatment and patient experience.
• Basavatarakam Indo American Cancer Hospital: Hyderabad-based comprehensive cancer specialty hospital offering medical, surgical and radiation oncology, research, and diagnostics. Comparable to MCC as a multi-modality standalone cancer center serving regional premium and mid-tier patients in India.

Broad incumbents

• Apollo Hospitals (Cancer/Oncology): Pan-India multi-specialty hospital chain operating a dedicated cancer institute with medical/surgical/radiation oncology, immunotherapy, and precision medicine. Comparable in offering a comprehensive cancer program but with vastly broader footprint, institutional brand, and payer relationships.
• Max Hospital (Max Institute of Cancer Care): Major Delhi-NCR-based hospital chain with dedicated oncology institute offering chemotherapy, immunotherapy, bone marrow transplant, and surgical oncology. Direct NCR competitor for premium oncology patients and corporate referrals.
• Fortis Memorial Research Institute (FMRI) Cancer Institute: Gurugram-based flagship of Fortis Healthcare's oncology program with comprehensive cancer care, daycare chemo, and robotic surgery. Strongest same-city competitor to MCC for premium Gurugaon/Delhi-NCR oncology patients.
• Tata Memorial Hospital (Tata Cancer Care): India's premier government-aided cancer specialty hospital in Mumbai offering comprehensive medical, surgical and radiation oncology. Comparable to MCC as a multi-modality oncology referral center, but at vastly larger scale, subsidized pricing, and a pan-India/NRI catchment.
• Medanta Cancer Institute (Medanta – The Medicity): Large Gurugram-based super-specialty hospital offering a dedicated cancer institute with hematology, BMT, medical/surgical/radiation oncology. Comparable on Gurugram catchment and comprehensive oncology service line.
• Mazumdar Shaw Medical Center (Narayana Health): Large Bangalore-based cancer center affiliated with Narayana Health providing high-volume, affordable specialty oncology including daycare chemo, immunotherapy, and precision medicine. Comparable as a comprehensive oncology specialist within a larger hospital system.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/mcc_gurgaon
• YouTubeyoutube.com/channel/UCJ6YqKd4uePvsLKff5He5aQ
• Facebookfacebook.com/MillenniumCancerCenter
• LinkedInlinkedin.com/company/millenniumcancercenter
• Instagraminstagram.com/millenniumcancercenter

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Millennium Cancer Center